Skip to main content
PLIANT THERAPEUTICS, INC. logo

PLIANT THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · PLRX ISIN · US7291391057 LEI · 5493002Q5LITR7VHZH02 US Professional, scientific and technical activities
Open in API
Filings indexed 403 across all filing types
Latest filing 2022-06-21 Director's Dealing
Country US United States of America
Listing US PLRX

About PLIANT THERAPEUTICS, INC.

https://pliantrx.com/

Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of fibrosis and related diseases. The company leverages its expertise in integrin biology to create tissue-specific treatments. Its therapeutic approach centers on modulating integrin activity and inhibiting TGF-β1 signaling, which are key molecular drivers of fibrosis. Pliant utilizes its proprietary discovery platform to advance a pipeline of integrin-based product candidates, aiming to provide safer and more effective therapies for patients.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2022-06-21 English
FORM 4
Director's Dealing
2022-06-21 English
FORM 4
Director's Dealing
2022-06-21 English
FORM 4
Director's Dealing
2022-06-21 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 16, 2022, reporting the submission of matters to a vote of security holders at the company's Annual Meeting. It details the voting results on several proposals including election of directors, advisory votes on executive compensation, and ratification of the independent auditor. The content focuses exclusively on the official results of shareholder votes at the Annual Meeting. There is no financial data, no full report, no presentation, and no other type of filing content. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 5222 characters, which is sufficient to contain detailed voting results rather than just an announcement of a report publication. Therefore, the correct classification is DVA with high confidence.
2022-06-17 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-06-10 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.